Vesal­ius bags €65M biotech fund while No­var­tis vet Gui­di can­vas­es for a €50M gam­ble on Ital­ian sci­en­tists

The Lux­em­bourg-based biotech ven­ture firm Vesal­ius Bio­cap­i­tal has raised more than €65 mil­lion for its third fund, which will re­main open in search of ad­di­tion­al …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.